Engineering at the nanometre scale

Founded in 2002, the centre has developed an international reputation in many fields that stretch traditional engineering concepts to the extreme.

This has been made possible by radical thinking that combines engineering with physics, chemistry, biology and medicine. The MNC has an active strategy to develop projects that bridge traditional disciplines to provide a step change in technology. Recent investment in the field of nanomedicine has led to the creation of a £22 million Centre for NanoHealth.

Links with industry

Work within the Multidisciplinary Nanotechnology Centre places a strong emphasis on the development of applications-driven research and the transfer of technology from the laboratory to the work place or health centre. Interaction with industry is therefore a key component of the Centre’s strategy and we have collaborated with major multi-national companies such as Agilent, Boots and Sharp, as well as a number of smaller Welsh-based companies.

The Centre for NanoHealth has established external network links nationally and internationally, for example with the European Technology Platform (ETP) Nanomedicine, XGEN, Texas/UK collaborative, and various Knowledge Transfer Networks in Electronics, Senors, Phontonics, and Nanotechnology, as well as HealthTech and Medicines.

 

Current funding awards

Nanomedicine research within the MNC is funded by over £2 million of research grants from the EPSRC for the development of new metrologies and nanoscale devices for the improvement of health.

Researchers at the MNC are collaborating with Welsh technology companies in a £470,000 research project backed by the Welsh Government’s EU funded Academic Expertise for Business (A4B) in the development of a hi-tech diabetes blood glucose monitor.

Revolutionising the way we live our lives

Nanotechnology
Nanotechnology

Centre facilities

The MNC’s state-of-the-art nanotechnology laboratory suite houses cutting-edge fabrication and characterisation facilities. Equipment includes:

• Two UHV Omicron Nanotechnology SPMs (1 STM/AFM, 1 STM/ESCA and 1 STM/SEM)
• Five Vecco AFMs (2 explorers, 1 Nanoman and 1 Picoforce)
• Two Vecco SNOMs (Aurora II and III)
• Five desktop SPM systems
• A variety of spectroscopic techniques are available (XPS, AES, confocal RAMAN, mass spectrometry, ICP spectroscopy and photo correlation spectroscopy for particle sizing down to 1nm)
• Laser diffraction particle sizing
• Free solution electrophoresis BT and gas porosimetry
• Microcalorimetry
• A comprehensive range of rheometers
• Gas liquid chromatography and HPLC

Other equipment includes a fully-equipped clean room for device fabrication, a new biotechnology pilot plant, pilot-scale membrane filtration equipment (micro- to nano-filtration) and reverse osmosis.